Israelis find biomarker linking genome instability, cancer
Ubiquilin-4 protein biomarker provides critical information about cancer tumors and patients' chances of responding to treatment.
JANUARY 20, 2019, 8:00 AM
Naama Barak is a writer at ISRAEL21c. A PhD student at the Hebrew University of Jerusalem, she loves all things history and politics. Food and fashion come a close second. Prior to joining ISRAEL21c, Naama worked for Israel's leading English-language dailies and cutting-edge startups.
No hay comentarios:
Publicar un comentario